Loading clinical trials...
Loading clinical trials...
Сlinical Trial of Efficacy, Safety and Immunogenicity of Combined Vector Vaccine Gam-COVID-Vac in SARS-СoV-2 Infection Prophylactic Treatment in Republic of Belarus
Conditions
Interventions
Gam-COVID-Vac
Placebo
Locations
8
Belarus
Health Institution "14th Central Regional Polyclinic of the Partisan district of Minsk"
Minsk, Belarus
Health Institution "19th Central Regional Polyclinic of the Pervomaysk district of Minsk"
Minsk, Belarus
Health Institution "1st Central Regional Clinical Polyclinic of the Central district of Minsk"
Minsk, Belarus
Health Institution "28th Regional Polyclinic of Minsk"
Minsk, Belarus
Health Institution "4th City Polyclinic of Minsk"
Minsk, Belarus
Health Institution "5th City Clinical Polyclinic of Minsk"
Minsk, Belarus
Start Date
September 28, 2020
Primary Completion Date
March 28, 2021
Completion Date
April 10, 2021
Last Updated
December 2, 2020
NCT04525716
NCT03188796
NCT06355232
NCT05191420
NCT04611243
NCT04678193
Lead Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions